Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) represents a considerable global health challenge, ranking third in incidence and second in mortality worldwide. However, existing therapies for diseases with advanced stages often fail, thereby necessitating the search for more comprehensive treatments. Oncolytic virus, a novel anticancer approach, exhibits promising capabilities in selectively targeting and destroying tumor cells while augmenting their efficacy through genetic engineering modifications. Anticipated as a new therapeutic paradigm for CRC, this study aimed to assess the performance of oncolytic virus in clinical trials and explore their potential synergies with other therapeutic modalities, offering insights into the future direction of CRC treatment.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: